Extended-release buprenorphine is approved as a once-monthly subcutaneous injection for the treatment of moderate-to-severe ...

As treatment for schizophrenia changes, LAIs are becoming increasingly important as maintenance therapy. Teva's pursuit of an ...

Onyda XR should not be substituted for other clonidine products on a mg-per-mg basis. The Food and Drug Administration (FDA) has approved Onyda XR (clonidine hydrochloride) extended-release oral ...

Please provide your email address to receive an email when new articles are posted on . An oral, ultra-long-acting, extended-release risperidone capsule provided sustained therapeutic levels of ...

The challenge of achieving sustained delivery of an active ingredient or nutrient can be achieved with extended-release formulations. To effectively treat many conditions, it is beneficial for the API ...

In a recent study published in the journal Nature Medicine, an international team of researchers evaluated the efficacy, safety, and tolerability of extended-release ketamine tablets (R-107) in adult ...

Kapvay is indicated for use as add-on therapy to stimulate medications. This formulation of clonidine is indicated for treating patients with ADHD, either as monotherapy or as adjunctive therapy to ...

(Reuters Health) - If doctors prescribed short-acting medications that must be taken twice a day instead of once-a-day extended-release versions, billions in healthcare costs could be saved, a new ...